Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trial

por Procopio, G, Verzoni, E, Bracarda, S, Ricci, S, Sacco, C, Ridolfi, L, Porta, C, Miceli, R, Zilembo, N, Bajetta, E
Publicado 2011

Endocrinological and clinical evaluation of two doses of formestane in advanced breast cancer.

por Bajetta, E., Zilembo, N., Buzzoni, R., Noberasco, C., Di Leo, A., Bartoli, C., Merson, M., Sacchini, V., Moglia, D., Celio, L.
Publicado 1994

Endocrinological and clinical evaluation of exemestane, a new steroidal aromatase inhibitor.

por Zilembo, N., Noberasco, C., Bajetta, E., Martinetti, A., Mariani, L., Orefice, S., Buzzoni, R., Di Bartolomeo, M., Di Leo, A., Laffranchi, A.
Publicado 1995

Combination goserelin and tamoxifen therapy in premenopausal advanced breast cancer: a multicentre study by the ITMO group. Italian Trials in Medical Oncology.

por Buzzoni, R., Biganzoli, L., Bajetta, E., Celio, L., Fornasiero, A., Mariani, L., Zilembo, N., Di Bartolomeo, M., Di Leo, A., Arcangeli, G.
Publicado 1995

Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised pha...

por Bajetta, E, Di Bartolomeo, M, Buzzoni, R, Mariani, L, Zilembo, N, Ferrario, E, Lo Vullo, S, Aitini, E, Isa, L, Barone, C, Jacobelli, S, Recaldin, E, Pinotti, G, Iop, A
Publicado 2007

Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma

por Ceresoli, G L, Zucali, P A, Mencoboni, M, Botta, M, Grossi, F, Cortinovis, D, Zilembo, N, Ripa, C, Tiseo, M, Favaretto, A G, Soto-Parra, H, De Vincenzo, F, Bruzzone, A, Lorenzi, E, Gianoncelli, L, Ercoli, B, Giordano, L, Santoro, A
Publicado 2013